0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
ARTICLE |

PELLAGRA: TRANSFUSION IN ELEVEN CASES

H. P. COLE, M.D.; GILMAN J. WINTHROP, M.D.
JAMA. 1910;LIV(17):1354-1356. doi:10.1001/jama.1910.92550430001001b.
Text Size: A A A
Published online

Confining ourselves to a consideration of the theories, experiments and facts bearing on the nature and action of the toxic substances of pellagra, no matter what be their origin, we suggest the possibility of combating these toxins in vivo by antagonistic substances existing in the body as the result of a natural or acquired immunity.

As evidence of the existence of specific toxic and antitoxic bodies the following facts may be noted:

Tizzoni1 has produced typical pellagrous symptoms in animals by injection of pellagrous human blood.

Lombroso2 claims to have produced typical pellagrous manifestations by the administration of an alcoholic extract of impure maize by mouth.

Babes3 and other workers have found in the serum of pellagrins a substance antagonistic to extracts of damaged maize, that is a specific antibody.

Giovanni and Gatti,4 from their work on pellagrous serum, conclude that the serum of pellagrins has a hemolytic action

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Letters

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();